Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 103

Results For "2022"

1413 News Found

IGSTC to propose joint AI initiative on healthcare and sustainability
Sustainability | May 05, 2022

IGSTC to propose joint AI initiative on healthcare and sustainability

This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems


JBCPL emerges as the fastest growing pharma company: Report
News | May 05, 2022

JBCPL emerges as the fastest growing pharma company: Report

Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22


TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea
Biotech | May 05, 2022

TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea

The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness


Israeli researchers warn about the return of Delta variant
News | May 05, 2022

Israeli researchers warn about the return of Delta variant

The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.


Eugia Pharma receives USFDA approval for Bortezomib
Drug Approval | May 04, 2022

Eugia Pharma receives USFDA approval for Bortezomib

The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA


New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
Healthcare | May 04, 2022

New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months


HPRA completes audit of Biocon Biologics New mAbs drug substance facility
Biotech | May 04, 2022

HPRA completes audit of Biocon Biologics New mAbs drug substance facility

The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency


Gland launches Bortezomib in the US market
Drug Approval | May 04, 2022

Gland launches Bortezomib in the US market

Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma


Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone
Biotech | May 02, 2022

Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone

The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023


Xcardia announces first-in-human use of its new Xtractor device
Biotech | May 02, 2022

Xcardia announces first-in-human use of its new Xtractor device

The announcement follows FDA 510(k) clearance of device